Laivoranta S, Ilonen J, Tuokko J, Luukkainen R, Toivanen A
Department of Medicine, Turku University, Finland.
Clin Exp Rheumatol. 1995 Sep-Oct;13(5):637-40.
The purpose of the present work was to find out whether there is an HLA type common to the patients who, in spite of being B27 negative, have developed reactive arthritis (ReA). We compared the HLA-antigens of 25 HLA-B27 negative ReA patients to those of healthy control persons. No statistically significant differences were observed in the HLA-A, B, C, DR and DQ antigen frequencies between the patients and the control group. The frequency of DR4 was slightly lower in the patients than in the controls, although this difference was not statistically significant. On the other hand, 18/25 (72%) of the B27-negative ReA patients experienced a chronic or prolonged course of the disease. These findings indicate that DR4 does not contribute to the chronicity of ReA in the same way that it is known to do in rheumatoid arthritis (RA) or Lyme arthritis. They do not support the hypothesis that some other HLA-antigen, in addition to HLA-B27, could have a predisposing or protective effect in ReA.
本研究的目的是查明,在尽管B27呈阴性但仍患反应性关节炎(ReA)的患者中,是否存在一种共同的HLA类型。我们将25例HLA - B27阴性的ReA患者的HLA抗原与健康对照者的进行了比较。患者与对照组之间在HLA - A、B、C、DR和DQ抗原频率上未观察到统计学上的显著差异。患者中DR4的频率略低于对照组,尽管这种差异无统计学意义。另一方面,25例B27阴性的ReA患者中有18例(72%)经历了慢性或病程迁延的情况。这些发现表明,DR4对ReA慢性病程的影响,与它在类风湿关节炎(RA)或莱姆关节炎中的作用方式不同。它们不支持这样的假说,即除HLA - B27外的其他一些HLA抗原在ReA中可能具有易患或保护作用。